Font Size: a A A
Keyword [hepatitis B cirrhosis]
Result: 181 - 200 | Page: 10 of 10
181. Assessment Of Renal Imaging Changes In Patients With Hepatitis B Cirrhosis By ARFI-VTQ And CDFI
182. The Relationship Between Neutrophil Lymphocyte Ratio(NLR),red Blood Cell Volume Distribution Width(RDW),and Hepatitis B And Liver Cirrhosis
183. Clinical Significance Of Serum Protoporphyrin ? Determination In Patients With Hepatitis B Cirrhosis
184. Analysis Of Clinical Characteristics And Risk Factors Of 169 Patients With Hepatitis B Cirrhosis And Kidney Injury
185. Distribution Of Traditional Chinese Medicine Syndromes Of Hepatitis B Cirrhosis Ascites (Bulge)and Its Correlation
186. Distribution Pattern Of TCM Syndromes Of Hepatitis B Cirrhosis(Compensation Period)and Related Research
187. Research Of The Nomogram To Predict The Risk Of Hepatitis B Cirrhosis Patients After Splenectomy Developing Into PVST
188. Analysis Of Risk Factors Of Acute Renal Injury In Patients With Decompensated Hepatitis B Cirrhosis
189. Type 2 Diabetes Is Associated With Increased Risk For Cirrhosis In Chronic Hepatitis B Patients Without Antiviral Therapy
190. Study On Intestinal Barrier Function And Microecology Of Patients With Hepatitis B Virus Cirrhosis
191. Clinical Study Of Entecavir Combined With Glucobay On Insulin Resistance In Patients With Hepatitis B Cirrhosis Complicated With Hepatogenic Diabetes
192. Study On The Effect Of Drug Zero-Profit Policy On The Cost Burden And Diagnosis And Treatment Of Patients With Chronic Hepatitis B Related Diseases
193. The Predictive Value Of FibroScan And GPRI In The Degree Of Esophageal Varices In Patients With Hepatitis B Cirrhosis
194. Changes Of Coagulation,Anticoagulation And Fibrinolysis System In Patients With Different Child-Pugh Grade Cirrhosis
195. Effects Of Integrated Treatment Of Traditional Chinese Medicine And Western Medicine On The Incidence Of Hepatocellular Carcinoma After Liver Cirrhosis With Hepatitis B
196. The Effect Of Collaboration Care For Adherence Behavior To Medical Treatments Of Rural Patients With Hepatitis B Cirrhosis
197. Correlation Between PNPLA3 And IFNLR1 Gene Polymorphisms And Response To Antiviral Therapy In Patients With Hepatitis B Cirrhosis
198. Based On The "Liver-gut Axis" Study Of Rougan Huaxian Granules To Regulate Intestinal Flora Imbalance And Treatment Of Compensated Hepatitis B Cirrhosis
199. Clinical Observation Of The Therapeutic Effect Of Rougan Huaxian Granule Combined With Entecavir In The Treatment Of Hepatitis B Cirrhosis(Syndrome Of Liver-kidney Yin Deficiency)
200. Clinical Observation Of Zhuanggan Zhuyu Decoction Combined With Entecavir In The Treatment Of Decompensated Period Of Hepatic Cirrhosis With Deficiency And Stasis Type B
  <<First  <Prev  Next>  Last>>  Jump to